Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A systemic IgA vasculitis that affects small vessels. It is characterized by skin purpura, arthritis, and abdominal and/or renal involvement.
Biomarker and diagnostic research for immunoglobulin A vasculitis has been reported in the published literature.
Estimated prevalence: Unknown (Unknown prevalence).
11 clinical trials registered, 9 recruiting. Interventions under study include drug therapy, other interventions, and medical devices. Pipeline includes 1 PHASE4, 2 PHASE3, 2 PHASE2. Research is sponsored by a mix of industry and academic institutions.
NCT ID | Title | Phase | Sponsor | Status |
|---|---|---|---|---|
[NCT05003986](https://clinicaltrials.gov/study/NCT05003986) |
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 1:54 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases |
PHASE2 |
Travere Therapeutics, Inc. |
RECRUITING |
[NCT02593565](https://clinicaltrials.gov/study/NCT02593565) | Vasculitis Pregnancy Registry | — | University of Pennsylvania | RECRUITING |
[NCT03004326](https://clinicaltrials.gov/study/NCT03004326) | Clinical Transcriptomics in Systemic Vasculitis (CUTIS) | — | Peter Merkel | RECRUITING |
[NCT07024563](https://clinicaltrials.gov/study/NCT07024563) | Study of Ravulizumab in Pediatric Participants With Primary IgAN | PHASE3 | Alexion Pharmaceuticals, Inc. | RECRUITING |
[NCT02967068](https://clinicaltrials.gov/study/NCT02967068) | VCRC Tissue Repository | — | University of Pennsylvania | RECRUITING |
245 publications have been identified in PubMed for immunoglobulin A vasculitis. Research spans Case Report / Case Series (33%), Epidemiology / Natural History (23%), and Review / Meta-Analysis (14%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 82 | 33% |
Disease patterns and progression | 56 | 23% |
Research summaries | 34 | 14% |
Laboratory research | 30 | 12% |
Testing and diagnosis research | 19 | 8% |
Clinical study results | 18 | 7% |
Other research | 3 | 1% |
New treatment approaches | 3 | 1% |
Xu S (2026). [PMID: 42136649](https://pubmed.ncbi.nlm.nih.gov/42136649/). *Front Immunol*. [Review / Meta-Analysis]
Şenol PE (2026). [PMID: 42084888](https://pubmed.ncbi.nlm.nih.gov/42084888/). *Turk Arch Pediatr*. [Epidemiology / Natural History]
Atchariyaphuk N (2026). [PMID: 41125223](https://pubmed.ncbi.nlm.nih.gov/41125223/). *Clinical and experimental pediatrics*. [Epidemiology / Natural History]
Lu J (2026). [PMID: 41475284](https://pubmed.ncbi.nlm.nih.gov/41475284/). *Int Immunopharmacol*. [Basic Science / Preclinical]
Yıldırım F (2026). [PMID: 41682802](https://pubmed.ncbi.nlm.nih.gov/41682802/). *J Clin Med*. [Diagnostic / Biomarker]
Cao D (2026). [PMID: 41194696](https://pubmed.ncbi.nlm.nih.gov/41194696/). *Clin Pediatr (Phila)*. [Epidemiology / Natural History]
Kılıç Sağlam M (2026). [PMID: 41753196](https://pubmed.ncbi.nlm.nih.gov/41753196/). *Journal of clinical medicine*. [Epidemiology / Natural History]
Jain A (2026). [PMID: 42179327](https://pubmed.ncbi.nlm.nih.gov/42179327/). *J Clin Rheumatol*. [Case Report / Case Series]
Bayir GK (2026). [PMID: 41792387](https://pubmed.ncbi.nlm.nih.gov/41792387/). *Rheumatology and therapy*. [Basic Science / Preclinical]
Roache-Robinson P (2026). [PMID: 30725937](https://pubmed.ncbi.nlm.nih.gov/30725937/). *Unknown Journal*. [Review / Meta-Analysis]